medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2002, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2002; 1 (4)


Evaluation of a third generation anti-HCV assay in predicting viremia in patients with positive HCV antibodies

Sookoian S, Castaño G

Idioma: Ingles.
Referencias bibliográficas: 12
Paginas: 179-182
Archivo PDF: 68.58 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Seeff LB. Natural history of hepatitis C. Hepatology 1997; 26(Suppl 1): 21S-8.

  2. Tong MJ, El-Farra NS., Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1436-66.

  3. Gretch D. National Institutes of Health Consensus Development Conference Panel Statement: Diagnostic test for Hepatitis C. Hepatology 1997; 26: 43S-47S.

  4. Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 34: 722-724.

  5. Busch M, Wilber J, Johnson P, Tobler L, Evans C. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992; 32: 420-425.

  6. Tung HD, Lu SN, Lee CM, Wang JH, Chen TM, Hung CH, Huang WS, et al. Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay. J Viral Hepat 2002; 9: 304-308.

  7. Chomczynski SP, Sacchi N. Single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987; 162: 156-159.

  8. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.

  9. Perniola R, De Rinaldis C, Leo G. Third-generation assays for hepatitis C antibodies: a four-year study of pattern changes in patients with chronic and past infection. Panminerva Med 1999; 41(4): 291-4.

  10. Lanotte P, Dubois F, Le Pogam S, Guerois C, Fimbel B, Bacq Y, Gruel Y, et al. The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed haemophiliacs. J Infect Dis 1998; 178(2): 556-9.

  11. Kondili LA, Chionne P, Costantino A, Villano U, Lo Nove C, Pannozzo F, Mele A, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50(5): 693-6.

  12. Baumert TF, Wellnitz S, Aono S, Satoi J, Herlon D, Tilman gerlach J, Page GR, et al. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology 2000; 32(3): 610-7.




2020     |     www.medigraphic.com